Patient_Reported_Outcome_Measures_in_Rheumatic_Diseases

(ff) #1
119


  1. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment
    strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind ran-
    domised controlled trial. Lancet. 2004;364(9430):263–9.

  2. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, Utrecht
    Rheumatoid Arthritis Cohort study group, et al. Intensive treatment with methotrexate in early
    rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid
    Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis. 2007;66(11):1443–9.

  3. Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, et al. Disease activity score
    driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis:
    data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis. 2011;70(4):611–5.

  4. Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Den Broeder AA, et al. A
    tight control treatment strategy aiming for remission in early rheumatoid arthritis is more
    effective than usual care treatment in daily clinical practice: a study of two cohorts in the
    Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis. 2012;71(6):845–50.

  5. El Miedany Y, El Gaafary M, Sayed S, Palmer D. Biomarkers and patient tailored approach
    in rheumatoid arthritis. Can PROMs be the missing biomarker. Ann Rheum Dis. 2015;74:1002.

  6. Aspinall SL, Good CB, Glassman PA, Valentino MA. The evolving use of cost-effectiveness
    analysis in formulary management within the Department of Veterans Affairs. Med Care.
    2005;43:20–6.

  7. Alishiri GH, Bayat N, Fathi Ashtiani A, Tavallaii SA, Assari S, Moharamzad Y. Logistic
    regression models for predicting physical and mental health-related quality of life in rheuma-
    toid arthritis patients. Mod Rheumatol. 2008;18(6):601–8.

  8. El Miedany Y, El Gaafary M, Youssef S, Ahmed I, Palmer D. The arthritic patients’ perspec-
    tive of measuring treatment effi cacy: patient reported experience measures (PREMs) as a
    quality tool. Clin Exp Rheumatol. 2014;32(4):547–52.

  9. Department of Health. Guidance on the routine collection of patient reported outcome mea-
    sures (PROMs). Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/
    Publications/Publications/PolicyAndGuidance/DH_091451. Accessed 19 Jun 2014.

  10. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication
    compliance and persistence: terminology and defi nitions. Value Health. 2008;11:44–7.

  11. Luqmani R, Hennell S, Estrach C, Birrell F, Bosworth A, Davenport G, British Society for
    Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and
    Audit Working Group, et al. British Society for Rheumatology and British Health
    Professionals in Rheumatology guideline for the management of rheumatoid arthritis (the
    fi rst two years). Rheumatology (Oxford). 2006;45(9):1167–9.

  12. Zbrozek A, Hebert J, Gogates G, Thorell R, Dell C, Molsen E, et al. Validation of electronic
    systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial
    teams: report of the ISPOR ePRO systems validation good research practices task force.
    Value Health. 2013;16(4):480–9.

  13. Bennett A, Jensen R, Basch E. Electronic patient-reported outcome systems in oncology
    clinical practice. CA Cancer J Clin. 2012;62:336–47.

  14. Maguire R, McCann L, Miller M, Kearney N. Nurse’s perceptions and experiences of using
    of a mobile-phone-based advanced symptom management system (ASyMS) to monitor and
    manage chemotherapy related toxicity. Eur J Oncol Nurs. 2008;12:380–6.

  15. El Miedany Y, El Gaafary M, Sayed S, Palmer D. Electronic patient reported outcome mea-
    sures (e-PROMs) for early arthritis in standard clinical practice: a pilot study. Ann Rheum
    Dis. 2015;74 Suppl 2:65.

  16. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA. et al; ISPOR ePRO task
    force. Recommendations on evidence needed to support measurement equivalence between
    electronic and paper based patient-reported outcome (PRO) measures: ISPOR ePRO good
    research practices task force report. Value Health. 2009;12(4):419–29.

  17. Horevoorts N, Vissers P, Mols F, et al. Response rates for patient-reported outcomes using
    web-based versus paper questionnaires: comparison of two invitational methods in older
    colorectal cancer patients. J Med Internet Res. 2015;17(5), e111. doi: 10.2196/jmir.3741.


4 PROMs for Rheumatoid Arthritis

Free download pdf